Highlights

Every report and update, newest first.

OUSTMay 26, 2026Latest
Ouster, Inc. - Position Close — Thesis Intact, Valuation Extended

Update on OUSTER and closure of position due to extended valuation

View →
OUSTMar 3, 2026
Ouster, Inc. - FY25 Earnings Update

Earnings update on Ouster, Inc. focused on the transition from LiDAR hardware vendor to full-stack AI and automation perception platform, opex and margin discipline, and the timing of margin inflection

View →
BFLYFeb 28, 2026
Butterfly Network, Inc. - FY25 Earnings Update

FY25 earnings update for Butterfly Network, Inc. (NYSE:BFLY) detailing shift to higher margin software and licensing revenue profile, platform economics, and change in strategic positioning

View →
OUSTFeb 23, 2026
Ouster, Inc. - From LiDAR to Full-Stack Perception

Initiation on Ouster, Inc. focused on the transition from LiDAR hardware vendor to full-stack AI and automation perception platform, opex and margin discipline, and the timing of margin inflection

View →
RAREJan 21, 2026
Ultragenyx Pharmaceuticals, Inc. (NASDAQ:RARE): From Peak Burn To Profitability

Initiation on Ultragenyx focused on the transition from peak burn to profitability—balancing commercial durability, pipeline optionality, and the timing of margin inflection.

View →
BFLYJan 15, 2026
Butterfly Network (NYSE:BFLY): Update Following J.P. Morgan Healthcare Presentation

Catalyst update following Butterfly Network's J.P. Morgan Healthcare discussion—summarizing commentary, roadmap updates, operating discipline, and the next 6–18 month signposts.

View →
BFLYDec 11, 2025
Butterfly Network (NYSE:BFLY): From Device Vendor to Semiconductor Imaging Platform

Initiation on Butterfly Network repositioning from a handheld ultrasound device vendor toward a semiconductor-enabled imaging platform—covering roadmap, unit economics, and inflection signposts.

View →
AVDLNov 21, 2025
Avadel Update: Four Bites In, Jazz Is Now The Natural Final Buyer

Follow-up note on Avadel with a refreshed buyer-universe view and scenario framing around strategic acquirers—highlighting why Jazz becomes the natural endpoint.

View →
AVDLOct 25, 2025
Avadel: Why The Alkermes Deal May Collapse And A Bidding War Could Follow

Event-driven update on Avadel's strategic positioning and M&A dynamics, focusing on the Alkermes transaction risk, potential competing bidders, and the signposts that would re-price deal probability.

View →

Get notified when new research drops

New reports and updates — no spam, unsubscribe anytime.

Atlantic Walk Research · Independent Equity Research